Search Results - "Goh, Pollyanna"
-
1
A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells
Published in PloS one (26-11-2013)“…A systematic evaluation of three different methods for generating induced pluripotent stem (iPS) cells was performed using the same set of parental cells in…”
Get full text
Journal Article -
2
Cerebral organoids with chromosome 21 trisomy secrete Alzheimer’s disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy
Published in Molecular psychiatry (01-02-2024)“…Understanding the role of small, soluble aggregates of beta-amyloid (Aβ) and tau in Alzheimer’s disease (AD) is of great importance for the rational design of…”
Get full text
Journal Article -
3
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Published in Cancer research (Chicago, Ill.) (01-09-2017)“…Histone lysine demethylases facilitate the activity of oncogenic transcription factors, including possibly MYC. Here we show that multiple histone demethylases…”
Get full text
Journal Article -
4
Generation of Integration-Free Patient Specific iPS Cells Using Episomal Plasmids Under Feeder Free Conditions
Published in Methods in molecular biology (Clifton, N.J.) (2016)“…Reprogramming somatic cells into a pluripotent state involves the overexpression of transcription factors leading to a series of changes that end in the…”
Get more information
Journal Article -
5
Modeling Down syndrome in cells: From stem cells to organoids
Published in Progress in brain research (2020)“…Down Syndrome (DS) is a complex chromosomal disorder, with neurological issues, featuring among the symptoms. Primary neuronal cells and tissues are extremely…”
Get more information
Journal Article -
6
-
7
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
Published in Molecular psychiatry (01-10-2021)“…A population of more than six million people worldwide at high risk of Alzheimer’s disease (AD) are those with Down Syndrome (DS, caused by trisomy 21 (T21)),…”
Get full text
Journal Article -
8
Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
Published in Acta neuropathologica communications (24-06-2020)“…Enlarged early endosomes have been visualized in Alzheimer's disease (AD) and Down syndrome (DS) using conventional confocal microscopy at a resolution…”
Get full text
Journal Article -
9
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis
Published in PloS one (13-04-2012)“…Transplantation of neural stem cells (NSCs) is a promising novel approach to the treatment of neuroinflammatory diseases such as multiple sclerosis (MS). NSCs…”
Get full text
Journal Article -
10
Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co‐express gamma and beta globins
Published in British journal of haematology (01-08-2014)“…Summary Human induced pluripotent stem cells (hiPSCs), like embryonic stem cells, are under intense investigation for novel approaches to model disease and for…”
Get full text
Journal Article -
11
Differential Coassembly of α1-GABA A Rs Associated with Epileptic Encephalopathy
Published in The Journal of neuroscience (15-07-2020)“…GABA receptors (GABA Rs) are profoundly important for controlling neuronal excitability. Spontaneous and familial mutations to these receptors feature…”
Get full text
Journal Article -
12
Differential Coassembly of α1-GABAARs Associated with Epileptic Encephalopathy
Published in The Journal of neuroscience (15-07-2020)“…GABAA receptors (GABAARs) are profoundly important for controlling neuronal excitability. Spontaneous and familial mutations to these receptors feature…”
Get full text
Journal Article -
13
Brief Report: Isogenic Induced Pluripotent Stem Cell Lines From an Adult With Mosaic Down Syndrome Model Accelerated Neuronal Ageing and Neurodegeneration
Published in Stem cells (Dayton, Ohio) (01-06-2015)“…Trisomy 21 (T21), Down Syndrome (DS) is the most common genetic cause of dementia and intellectual disability. Modeling DS is beginning to yield pharmaceutical…”
Get full text
Journal Article -
14
Alzheimer‐like pathology in trisomy 21 cerebral organoids amenable to pharmacological inhibition reveals BACE2 as a gene‐dose‐sensitive AD‐suppressor in human brain: Development of new models and analysis methods: Multisystem platform models of ADRD
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background A population of >6 million people worldwide at high risk of Alzheimer’s disease (AD) are those with Down Syndrome (DS, caused by trisomy 21…”
Get full text
Journal Article -
15
Alzheimer‐like pathology in trisomy 21 cerebral organoids amenable to pharmacological inhibition reveals BACE2 as a gene‐dose‐sensitive AD‐suppressor in human brain
Published in Alzheimer's & dementia (01-12-2020)“…Background A population of >6 million people worldwide at high risk of Alzheimer’s disease (AD) are those with Down Syndrome (DS, caused by trisomy 21 (T21)),…”
Get full text
Journal Article -
16
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts
Published in International journal of stem cells (30-11-2018)“…Mbd3 (Methyl-CpG binding domain protein), a core member of NuRD (nucleosome remodelling and deacetylation) is essential for embryogenesis. However, its role in…”
Get full text
Journal Article -
17
Mislocalisation of BEST1 in iPSC-derived retinal pigment epithelial cells from a family with autosomal dominant vitreoretinochoroidopathy (ADVIRC)
Published in Scientific reports (22-09-2016)“…Autosomal dominant vitreoretinochoroidopathy (ADVIRC) is a rare, early-onset retinal dystrophy characterised by distinct bands of circumferential pigmentary…”
Get full text
Journal Article -
18
GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER’S PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article -
19
Correction: Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis
Published in PloS one (21-06-2012)Get full text
Journal Article -
20
[P3–168]: GENETIC DISSECTION OF SEVERITY AND ONSET MODULATORS FOR ALZHEIMER's PATHOLOGY IN DOWN SYNDROME USING CELLULAR SYSTEMS
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article